Extensions

To provide a comprehensive analysis of U.S. Patent No. 11,974,910, I have accessed and reviewed the official records from the United States Patent and Trademark Office (USPTO). Here is a detailed breakdown of the patent's term, related applications, and family members.

Patent Term and Expiration

• Filing Date: June 27, 2023
• Grant Date: May 7, 2024
• Statutory Term: The standard term for a U.S. utility patent is 20 years from the earliest effective filing date. The application for this patent (18/342,553) has a priority claim to a provisional application filed on August 13, 2018. Therefore, the base expiration date would be 20 years from that priority date.
• Patent Term Adjustment (PTA): There is no Patent Term Adjustment (PTA) indicated for this patent. PTA is granted to compensate for delays in the patenting process caused by the USPTO.
• Patent Term Extension (PTE): There is no Patent Term Extension (PTE) noted for this patent. PTE is typically granted for patents covering products that undergo a lengthy regulatory review process, such as pharmaceuticals.

Based on this information, the projected expiration date for U.S. Patent No. 11,974,910 is August 13, 2038.

Continuity and Related Applications

U.S. Patent No. 11,974,910 is part of a larger family of related patent applications. This indicates an ongoing strategy by Inari Medical to protect various aspects of its technology. The specific relationships are as follows:

• Parent Application: This patent is a continuation of U.S. Patent Application No. 18/342,553, filed on June 27, 2023, which is now U.S. Patent No. 11,974,910 itself.
• Priority Data: This patent claims priority to the following U.S. Provisional Applications:
  • 62/718,369, filed on August 13, 2018.
  • 62/820,741, filed on March 19, 2019.

This chain of applications demonstrates a continued development and refinement of the invention over time.

International Patent Family

In addition to the U.S. filings, Inari Medical has sought patent protection for this technology in other jurisdictions, creating an international patent family. These related foreign applications and patents include:

• Australia (AU)
• Canada (CA)
• China (CN)
• Europe (EP)
• Japan (JP)
• Worldwide (WO)

The existence of this international patent family underscores the global commercial importance of the technology described in US Patent 11,974,910.

This information provides a comprehensive overview of the status and family of U.S. Patent No. 11,974,910, reflecting a robust and ongoing intellectual property strategy by Inari Medical, Inc.